A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Perspective Therapeutics
HiFiBiO Therapeutics
Tango Therapeutics, Inc.
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Ipsen
Prelude Therapeutics
Ipsen
Quadriga Biosciences, Inc.
MacroGenics
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Precision Therapeutics
Astellas Pharma Inc